Annual SGA
$488.43 M
+$81.87 M+20.14%
December 31, 2024
Summary
- As of March 10, 2025, ACAD annual SGA is $488.43 million, with the most recent change of +$81.87 million (+20.14%) on December 31, 2024.
- During the last 3 years, ACAD annual SGA has risen by +$92.40 million (+23.33%).
- ACAD annual SGA is now at all-time high.
Performance
ACAD SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$130.08 M
-$3.21 M-2.41%
December 31, 2024
Summary
- As of March 10, 2025, ACAD quarterly SGA is $130.08 million, with the most recent change of -$3.21 million (-2.41%) on December 31, 2024.
- Over the past year, ACAD quarterly SGA has increased by +$18.61 million (+16.70%).
- ACAD quarterly SGA is now -2.41% below its all-time high of $133.29 million, reached on September 30, 2024.
Performance
ACAD Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$9.35 B
+$226.45 M+2.37%
December 31, 2024
Summary
- As of March 10, 2025, ACAD TTM SGA is -$9.35 billion, with the most recent change of +$226.45 million (+2.37%) on December 31, 2024.
- Over the past year, ACAD TTM SGA has dropped by -$9.75 billion (-2399.23%).
- ACAD TTM SGA is now -13573.03% below its all-time high of -$68.37 million.
Performance
ACAD TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ACAD Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.1% | +16.7% | -2399.2% |
| 3 y3 years | +23.3% | +22.8% | -2460.4% |
| 5 y5 years | +50.0% | +41.6% | -2970.6% |
ACAD Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +32.3% | -2.4% | +66.5% | -11.1% | +4.0% |
| 5 y | 5-year | at high | +50.0% | -2.4% | +66.5% | -43.4% | +4.0% |
| alltime | all time | at high | >+9999.0% | -2.4% | +8701.1% | <-9999.0% | +4.0% |
ACADIA Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $488.43 M(+20.1%) | $130.08 M(-2.4%) | $488.43 M(+4.0%) |
| Sep 2024 | - | $133.29 M(+13.9%) | $469.81 M(+8.1%) |
| Jun 2024 | - | $117.06 M(+8.4%) | $434.41 M(+5.1%) |
| Mar 2024 | - | $107.99 M(-3.1%) | $413.31 M(+1.7%) |
| Dec 2023 | $406.56 M(+10.2%) | $111.47 M(+13.9%) | $406.56 M(+1.8%) |
| Sep 2023 | - | $97.89 M(+2.0%) | $399.50 M(+5.2%) |
| Jun 2023 | - | $95.97 M(-5.2%) | $379.71 M(+1.6%) |
| Mar 2023 | - | $101.23 M(-3.0%) | $373.65 M(+1.2%) |
| Dec 2022 | $369.09 M(-6.8%) | $104.40 M(+33.7%) | $369.09 M(-0.4%) |
| Sep 2022 | - | $78.11 M(-13.1%) | $370.60 M(-1.0%) |
| Jun 2022 | - | $89.90 M(-7.0%) | $374.16 M(-1.8%) |
| Mar 2022 | - | $96.68 M(-8.7%) | $381.05 M(-3.8%) |
| Dec 2021 | $396.03 M(+1.9%) | $105.91 M(+29.7%) | $396.03 M(-3.6%) |
| Sep 2021 | - | $81.67 M(-15.6%) | $410.87 M(+0.0%) |
| Jun 2021 | - | $96.79 M(-13.3%) | $410.79 M(+3.1%) |
| Mar 2021 | - | $111.66 M(-7.5%) | $398.35 M(+2.5%) |
| Dec 2020 | $388.66 M(+19.4%) | $120.75 M(+48.0%) | $388.66 M(+8.0%) |
| Sep 2020 | - | $81.59 M(-3.3%) | $359.78 M(+2.5%) |
| Jun 2020 | - | $84.34 M(-17.3%) | $350.88 M(+4.9%) |
| Mar 2020 | - | $101.97 M(+11.0%) | $334.52 M(+2.7%) |
| Dec 2019 | $325.64 M(+22.5%) | $91.87 M(+26.4%) | $325.64 M(+5.7%) |
| Sep 2019 | - | $72.70 M(+6.9%) | $308.04 M(+3.9%) |
| Jun 2019 | - | $67.98 M(-27.0%) | $296.43 M(-0.5%) |
| Mar 2019 | - | $93.09 M(+25.3%) | $297.92 M(+12.1%) |
| Dec 2018 | $265.76 M(+4.2%) | $74.27 M(+21.6%) | $265.76 M(+2.9%) |
| Sep 2018 | - | $61.09 M(-12.1%) | $258.18 M(-0.2%) |
| Jun 2018 | - | $69.47 M(+14.0%) | $258.68 M(+3.3%) |
| Mar 2018 | - | $60.93 M(-8.6%) | $250.33 M(-1.9%) |
| Dec 2017 | $255.06 M(+36.8%) | $66.69 M(+8.3%) | $255.06 M(+3.7%) |
| Sep 2017 | - | $61.59 M(+0.8%) | $246.04 M(+4.7%) |
| Jun 2017 | - | $61.13 M(-6.9%) | $234.98 M(+4.6%) |
| Mar 2017 | - | $65.66 M(+13.9%) | $224.63 M(+20.5%) |
| Dec 2016 | $186.46 M(+111.2%) | $57.66 M(+14.1%) | $186.46 M(+23.1%) |
| Sep 2016 | - | $50.53 M(-0.5%) | $151.41 M(+24.9%) |
| Jun 2016 | - | $50.77 M(+84.7%) | $121.18 M(+32.4%) |
| Mar 2016 | - | $27.49 M(+21.6%) | $91.53 M(+3.7%) |
| Dec 2015 | $88.30 M(+169.6%) | $22.62 M(+11.4%) | $88.30 M(+16.0%) |
| Sep 2015 | - | $20.31 M(-3.8%) | $76.11 M(+19.2%) |
| Jun 2015 | - | $21.12 M(-13.0%) | $63.86 M(+26.0%) |
| Mar 2015 | - | $24.26 M(+132.8%) | $50.69 M(+54.8%) |
| Dec 2014 | $32.75 M(+157.5%) | $10.42 M(+29.3%) | $32.75 M(+23.1%) |
| Sep 2014 | - | $8.06 M(+1.3%) | $26.61 M(+19.1%) |
| Jun 2014 | - | $7.95 M(+25.8%) | $22.34 M(+32.3%) |
| Mar 2014 | - | $6.32 M(+47.8%) | $16.89 M(+32.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | $12.72 M(+81.7%) | $4.28 M(+12.6%) | $12.72 M(+18.4%) |
| Sep 2013 | - | $3.80 M(+52.1%) | $10.74 M(+27.4%) |
| Jun 2013 | - | $2.50 M(+16.0%) | $8.43 M(+12.6%) |
| Mar 2013 | - | $2.15 M(-6.4%) | $7.49 M(+7.0%) |
| Dec 2012 | $7.00 M(-8.0%) | $2.30 M(+54.7%) | $7.00 M(+13.3%) |
| Sep 2012 | - | $1.49 M(-4.6%) | $6.18 M(-0.5%) |
| Jun 2012 | - | $1.56 M(-6.3%) | $6.21 M(-15.9%) |
| Mar 2012 | - | $1.66 M(+12.3%) | $7.39 M(-2.9%) |
| Dec 2011 | $7.61 M(+17.8%) | $1.48 M(-2.7%) | $7.61 M(-0.5%) |
| Sep 2011 | - | $1.52 M(-44.3%) | $7.65 M(-0.8%) |
| Jun 2011 | - | $2.73 M(+44.9%) | $7.71 M(+18.0%) |
| Mar 2011 | - | $1.88 M(+24.1%) | $6.53 M(+1.1%) |
| Dec 2010 | $6.46 M(-37.2%) | $1.52 M(-3.8%) | $6.46 M(-14.8%) |
| Sep 2010 | - | $1.58 M(+1.7%) | $7.58 M(-5.2%) |
| Jun 2010 | - | $1.55 M(-14.4%) | $8.00 M(-12.2%) |
| Mar 2010 | - | $1.81 M(-31.3%) | $9.11 M(-11.4%) |
| Dec 2009 | $10.28 M(-13.0%) | $2.64 M(+32.3%) | $10.28 M(+2.5%) |
| Sep 2009 | - | $1.99 M(-25.1%) | $10.03 M(-8.9%) |
| Jun 2009 | - | $2.66 M(-10.9%) | $11.01 M(-4.5%) |
| Mar 2009 | - | $2.99 M(+25.0%) | $11.54 M(-2.4%) |
| Dec 2008 | $11.82 M(-3.7%) | $2.39 M(-19.6%) | $11.82 M(-5.0%) |
| Sep 2008 | - | $2.97 M(-6.6%) | $12.44 M(+0.3%) |
| Jun 2008 | - | $3.18 M(-2.6%) | $12.40 M(+0.2%) |
| Mar 2008 | - | $3.27 M(+8.6%) | $12.38 M(+1.0%) |
| Dec 2007 | $12.27 M(+8.1%) | $3.01 M(+2.3%) | $12.27 M(+4.0%) |
| Sep 2007 | - | $2.94 M(-7.0%) | $11.79 M(-0.2%) |
| Jun 2007 | - | $3.16 M(+0.3%) | $11.81 M(+0.4%) |
| Mar 2007 | - | $3.15 M(+24.2%) | $11.76 M(+8.0%) |
| Dec 2006 | $11.35 M(-28.7%) | $2.54 M(-14.3%) | $10.89 M(-39.5%) |
| Sep 2006 | - | $2.96 M(-4.8%) | $18.01 M(+4.3%) |
| Jun 2006 | - | $3.11 M(+36.3%) | $17.27 M(+5.3%) |
| Mar 2006 | - | $2.28 M(-76.3%) | $16.40 M(+3.1%) |
| Dec 2005 | $15.91 M(+119.6%) | $9.65 M(+334.3%) | $15.91 M(+88.9%) |
| Sep 2005 | - | $2.22 M(-0.8%) | $8.43 M(+3.0%) |
| Jun 2005 | - | $2.24 M(+24.6%) | $8.18 M(+10.0%) |
| Mar 2005 | - | $1.80 M(-16.9%) | $7.44 M(+2.6%) |
| Dec 2004 | $7.25 M(+73.2%) | $2.16 M(+9.3%) | $7.25 M(+42.6%) |
| Sep 2004 | - | $1.98 M(+32.5%) | $5.08 M(+63.9%) |
| Jun 2004 | - | $1.49 M(-7.0%) | $3.10 M(+93.0%) |
| Mar 2004 | - | $1.61 M | $1.61 M |
| Dec 2003 | $4.18 M(+5.1%) | - | - |
| Dec 2002 | $3.98 M(+6.0%) | - | - |
| Dec 2001 | $3.76 M(+25.2%) | - | - |
| Dec 2000 | $3.00 M | - | - |
FAQ
- What is ACADIA Pharmaceuticals annual SGA?
- What is the all time high annual SGA for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual SGA year-on-year change?
- What is ACADIA Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly SGA year-on-year change?
- What is ACADIA Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals TTM SGA year-on-year change?
What is ACADIA Pharmaceuticals annual SGA?
The current annual SGA of ACAD is $488.43 M
What is the all time high annual SGA for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual SGA is $488.43 M
What is ACADIA Pharmaceuticals annual SGA year-on-year change?
Over the past year, ACAD annual SGA has changed by +$81.87 M (+20.14%)
What is ACADIA Pharmaceuticals quarterly SGA?
The current quarterly SGA of ACAD is $130.08 M
What is the all time high quarterly SGA for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly SGA is $133.29 M
What is ACADIA Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, ACAD quarterly SGA has changed by +$18.61 M (+16.70%)
What is ACADIA Pharmaceuticals TTM SGA?
The current TTM SGA of ACAD is -$9.35 B
What is the all time high TTM SGA for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high TTM SGA is -$68.37 M
What is ACADIA Pharmaceuticals TTM SGA year-on-year change?
Over the past year, ACAD TTM SGA has changed by -$9.75 B (-2399.23%)